Yang et al. have shown that TAZ promotes cell proliferation and tumor formation in U87 and LN229 cells by activating EGFR (Epidermal growth factor receptor) and its downstream AKT and ERK pathways through c-MYC [72]. The gene discussed is EGFR; the disease is neoplasm.